The Role of PPARin the Transcriptional Control by Agonists and Antagonists
Open Access
- 1 January 2012
- journal article
- review article
- Published by Wiley in PPAR Research
- Vol. 2012, 1-9
Abstract
In recent years, peroxisome proliferator-activated receptor gamma (PPARγ) has been reported to be a target for the treatment of type II diabetes. Furthermore, it has received attention for its therapeutic potential in many other human diseases, including atherosclerosis, obesity, and cancers. Recent studies have provided evidence that the endogenously produced PPARγ antagonist, 2,3-cyclic phosphatidic acid (cPA), which is similar in structure to lysophosphatidic acid (LPA), inhibits cancer cell invasion and metastasisin vitroandin vivo. We recently observed that cPA negatively regulates PPARγ function by stabilizing the binding of the corepressor protein, silencing mediator of retinoic acid and thyroid hormone receptor. We also showed that cPA prevents neointima formation, adipocyte differentiation, lipid accumulation, and upregulation of PPARγ target gene transcription. We then analyzed the molecular mechanism of cPA's action on PPARγ. In this paper, we summarize the current knowledge on the mechanism of PPARγ-mediated transcriptional activity and transcriptional repression in response to novel lipid-derived ligands, such as cPA.Keywords
Funding Information
- Japan Society for the Promotion of Science (22591482)
- Astellas Foundation (22591482)
- Takeda Science Foundation (22591482)
This publication has 105 references indexed in Scilit:
- Epigenetics: Principles and PracticeDigestive Diseases, 2011
- Epigenetic codes of PPARγ in metabolic diseaseFEBS Letters, 2011
- Endogenous Ligands for Nuclear Receptors: Digging DeeperJournal of Biological Chemistry, 2010
- Nuclear Receptor Corepressor SMRT Regulates Mitochondrial Oxidative Metabolism and Mediates Aging-Related Metabolic DeteriorationCell Metabolism, 2010
- Phospholipase D2-Dependent Inhibition of the Nuclear Hormone Receptor PPARγ by Cyclic Phosphatidic AcidMolecular Cell, 2010
- Cyclic phosphatidic acid — A unique bioactive phospholipidBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Molecular recognition of nitrated fatty acids by PPARγNature Structural & Molecular Biology, 2008
- Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acidBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and MetastasisJournal of Biological Chemistry, 2006
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994